Exploring the value of quality molecular diagnostics and real world data in the face of constrained resources

SPOT/Dx Working Group, Summary of Themes, April 2014

On March 31 – April 1, 2014, the Sustainable Predictive Oncology Therapeutics and Diagnostics Working Group (SPOT/Dx) convened for its second meeting in Arlington, Virginia. Please see the meeting summary below for a list of meeting participants. The meeting took place amidst an increasingly dynamic political and economic period for healthcare where patient need and quality care must contend with resource constraints. On the heels of the newly passed Protecting Access to Medicare Act of 2014, participants discussed the law’s impact on their ability to deliver personalized oncology treatment in a sustainable and valuable way. The meeting was also an opportune time for participants to consider new models for: 1) improving molecular diagnostic quality and 2) harnessing real world evidence to advance the development and administration of precision oncology and improve patient outcomes. The meeting enabled participants to clarify outstanding concerns and begin shaping roadmaps in service of these topics. This document summarizes key themes from the meeting.